La Flucytosine en 1984

J. E. Bennett

doi:10.1016/S0399-077X(85)80006-8

La Flucytosine en 1984

Translated title of the contribution: Flucytosine in 1984

J. E. Bennett

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

Translated title of the contribution	Flucytosine in 1984
Original language	French
Pages (from-to)	332-336
Number of pages	5
Journal	Medecine et Maladies Infectieuses
Volume	15
Issue number	6
DOIs	https://doi.org/10.1016/S0399-077X(85)80006-8
State	Published - Jun 1985
Externally published	Yes

Keywords

5-fluorocytosine
5-fluorouracil
Candidiasis-Cryptococcosis
Flucytosine

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S0399-077X(85)80006-8

Cite this

@article{d7565d56c12c42aba10991ae418c2fa5,

title = "La Flucytosine en 1984",

abstract = "Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.",

keywords = "5-fluorocytosine, 5-fluorouracil, Candidiasis-Cryptococcosis, Flucytosine",

author = "Bennett, {J. E.}",

year = "1985",

month = jun,

doi = "10.1016/S0399-077X(85)80006-8",

language = "French",

volume = "15",

pages = "332--336",

journal = "Medecine et Maladies Infectieuses",

issn = "0399-077X",

publisher = "Elsevier Masson",

number = "6",

}

TY - JOUR

T1 - La Flucytosine en 1984

AU - Bennett, J. E.

PY - 1985/6

Y1 - 1985/6

N2 - Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

AB - Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

KW - 5-fluorocytosine

KW - 5-fluorouracil

KW - Candidiasis-Cryptococcosis

KW - Flucytosine

UR - http://www.scopus.com/inward/record.url?scp=0022006807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022006807&partnerID=8YFLogxK

U2 - 10.1016/S0399-077X(85)80006-8

DO - 10.1016/S0399-077X(85)80006-8

M3 - Article

AN - SCOPUS:0022006807

SN - 0399-077X

VL - 15

SP - 332

EP - 336

JO - Medecine et Maladies Infectieuses

JF - Medecine et Maladies Infectieuses

IS - 6

ER -

La Flucytosine en 1984

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this